Literature DB >> 18228086

Experimental study on low pulse energy processing with femtosecond lasers for glaucoma treatment.

D X Hou1, D L Butler, L M He, H Y Zheng.   

Abstract

The feasibility of low energy processing in ocular tissues with femtosecond laser sources was investigated in this research. One laser source was a femtosecond amplifier, and the other was a femtosecond oscillator. The amplifier used in this experiment was a CPA-2001 (Clark-MXR, Inc), with 150 fs pulse duration and 1 kHz repetition rate. The femtosecond oscillator (model 900-B Mira) produced a 200 fs pulse duration and a 76 MHz repetition rate. Both these two laser systems operated at 800 nm wavelengths. Firstly, the pulse intensity thresholds in water produced by the two laser sources were compared. The optical breakdown probability analysis shows that the pulse energy threshold achieved by the oscillator was less than 10% of that achieved by the amplifier. Then, the non-linear propagation of the femtosecond pulses in the ocular tissues was studied with the femtosecond oscillator. The results showed a potential for pulse energy processing at the nanojoule level with a femtosecond oscillator in glaucoma treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18228086     DOI: 10.1007/s10103-008-0540-8

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  3 in total

1.  Femtosecond laser photodisruption of human trabecular meshwork: an in vitro study.

Authors:  Sami Toyran; Yaoming Liu; Sima Singha; Sun Shan; Michael R Cho; Robert J Gordon; Deepak P Edward
Journal:  Exp Eye Res       Date:  2005-09       Impact factor: 3.467

2.  Pulse energy dependence of subcellular dissection by femtosecond laser pulses.

Authors:  A Heisterkamp; I Z Maxwell; E Mazur; J M Underwood; J A Nickerson; S Kumar; D E Ingber
Journal:  Opt Express       Date:  2005-05-16       Impact factor: 3.894

3.  Intratissue surgery with 80 MHz nanojoule femtosecond laser pulses in the near infrared.

Authors:  Karsten Koenig; Oliver Krauss; Iris Riemann
Journal:  Opt Express       Date:  2002-02-11       Impact factor: 3.894

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.